Co-Authors
This is a "connection" page, showing publications co-authored by Martin Bachmann and Mona Mohsen.
Connection Strength
1.419
-
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy. 2022 01; 77(1):111-117.
Score: 0.242
-
Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction. Allergy. 2022 01; 77(1):143-149.
Score: 0.240
-
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy. 2021 09; 76(9):2895-2998.
Score: 0.237
-
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines (Basel). 2021 Apr 19; 9(4).
Score: 0.235
-
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines (Basel). 2021 Apr 16; 9(4).
Score: 0.235
-
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. NPJ Vaccines. 2021 Jan 04; 6(1):2.
Score: 0.231